Response to the letter by Mol

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):106. doi: 10.1002/pds.3519.

Authors

Becky A Briesacher¹, Stephen B Soumerai, Fang Zhang, Sengwee Toh, Susan E Andrade, Joann L Wagner, Azadeh Shoaibi, Jerry H Gurwitz

Affiliation

¹ Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, MA, USA; Meyers Primary Care Institute, a joint endeavor of Fallon Community Health Plan, Reliant Medical Group and the University of Massachusetts Medical School, Worcester, MA, USA.

PMID: 24395548
DOI: 10.1002/pds.3519

No abstract available

Publication types

Letter
Research Support, U.S. Gov't, P.H.S.
Comment

MeSH terms

Consumer Product Safety / legislation & jurisprudence*
Drug Approval / legislation & jurisprudence*
Drug Labeling / legislation & jurisprudence*
Endpoint Determination / methods*
Government Regulation*
Research Design*

Grants and funding